Edition:
India

Catalent Inc (CTLT.N)

CTLT.N on New York Stock Exchange

43.37USD
16 Feb 2018
Change (% chg)

$0.50 (+1.17%)
Prev Close
$42.87
Open
$42.76
Day's High
$43.69
Day's Low
$42.20
Volume
219,228
Avg. Vol
293,873
52-wk High
$47.86
52-wk Low
$27.48

Select another date:

Mon, Feb 5 2018

BRIEF-Catalent Posts Q2 Loss Per Share $0.16

* QTRLY ‍REVENUE OF $606.3 MILLION INCREASED 25% AS-REPORTED, OR 22 PCT IN CONSTANT CURRENCY FROM PRIOR-YEAR PERIOD​

BRIEF-Catalent Q1 earnings per share $0.03

* Q1 earnings per share view $0.17 -- Thomson Reuters I/B/E/S

BRIEF-Catalent completes repricing and extension of credit agreement

* Catalent completes repricing and extension of credit agreement Source text for Eikon: Further company coverage:

BRIEF-Catalent announces pricing of private offering of senior unsecured notes due 2026

* Catalent announces pricing of private offering of senior unsecured notes due 2026

BRIEF-Catalent launches private offering of $450 mln of senior unsecured notes due 2026

* Catalent announces launch of private offering of $450 million of senior unsecured notes due 2026

BRIEF-Catalent Inc announces pricing of public offering

* Catalent Inc announces pricing of public offering of common stock to fund part of its acquisition of Cook Pharmica

BRIEF-Catalent announces public offering of common stock to fund part of its acquisition of Cook Pharmica

* Catalent Inc announces public offering of common stock to fund part of its acquisition of Cook Pharmica

BRIEF-Catalent files for common stock offering of upto $‍​250 million

* Catalent Inc - files for common stock offering of upto $‍​250.0 million- SEC Filing Source text:(http://bit.ly/2xGCzV4) Further company coverage:

Catalent bolsters biopharma business with Cook Pharmica buy

U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.

UPDATE 2-Catalent bolsters biopharma business with Cook Pharmica buy

Sept 19 U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.

Select another date: